Latest Tweets
In response to significant ongoing disruption to the supply of Fluoxetine 30mg capsules and Salazopyrin® EN-Tabs 500mg, two Serious Shortage Protocols (SSPs) have been been issued by the Department of Health and Social Care (DHSC). Introduced with immediate effect today, Tuesday 20th October 2020, SSP07 has been developed by clinicians and provides pharmacists with procedures to...
16 hours ago
PSNC Briefing 037/20: Serious Shortage Protocol (SSP): SSP08 – Salazopyrin® EN-Tabs 500mg
In response to significant ongoing disruption to the supply of Salazopyrin® EN-Tabs 500mg, a Serious Shortage Protocol (SSP) have been issued by the Department of Health and Social Care (DHSC) and these can be accessed on the NHS Business Services Authority (NHSBSA) website. This briefing provides information on these SSPs and is intended as a...
16 hours ago
PSNC Briefing 036/20: Serious Shortage Protocol (SSP): SSP07 – Fluoxetine 30mg capsules
In response to significant ongoing disruption to the supply of fluoxetine 30mg capsules, a Serious Shortage Protocol (SSP) have been issued by the Department of Health and Social Care (DHSC) and these can be accessed on the NHS Business Services Authority (NHSBSA) website. This briefing provides information on these SSPs and is intended as a...
16 hours ago
The Pharmaceutical Needs Assessment (PNA) looks at the current provision of pharmaceutical services across the relevant Health and Wellbeing Board area. The PNA is a key document which will be used by NHS England to inform decisions regarding applications for new or changes to existing pharmaceutical services.
Local authorities have now published new PNAs for 2018-2021 which can be found below.
Last Updated: 19th February 2019